Elsevier: Goodman & Snyder: Differential Diagnosis for Physical Therapists Screening for Referral, 5th Edition - Chapter 8 Screening for Gastrointestinal Disease

Chapter 8 Screening for Gastrointestinal Disease

  1. Pert CB, Dreher HE, Ruff MR: The psychosomatic network: foundations of mind-body medicine. Altern Ther Health Med 4(4):30–41, 1998. Medline abstracts
  2. Pert C: Paradigms from neuroscience: when shift happens. Mol Interv 3(7):361–366, 2003. Medline abstracts
  3. Mayer EA: Gut feelings: what turns them on? Gastroenterology 108(3):927–931, 1995. Medline abstracts
  4. Groh V, Spies T: Recognition of stress-induced MHC molecules by intestinal epithelial gamma delta T cells. Science 279:1737–1740, 1998. Medline abstracts
  5. Wu J, et al: T-cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial gamma delta T cells. J Immunol 169(3):1236–1240, 2002. Medline abstracts
  6. Rex L: Evaluation and treatment of somatovisceral dysfunction of the gastrointestinal system, Edmonds, WA, 2004, URSA Foundation.
  7. Rose SJ, Rothstein JM: Muscle mutability: general concepts and adaptations to altered patterns of use. Phys Ther 62:1773, 1982.
  8. Ledlie J, Renfro M: Balloon kyphoplasty: one-year outcomes in vertebral body height restoration, chronic pain, and activity levels. J Neurosurg (Spine I) 98:36–42, 2003.
  9. Longstreth GF: Functional bowel disorders: revised Rome II diagnostic criteria for functional bowel disorders. Gastroenterology 130(5):1480–1491, 2006. Medline abstracts
  10. Spiller R: Do the symptom-based, Rome criteria of irritable bowel syndrome lead to better diagnosis and treatment outcomes? Clin Gastroenterol Hepatol 8(2):125–129, 2010. Medline abstracts
  11. Travell JG, Simons DG: Myofascial pain and dysfunction: the trigger point manual, vol 2, Baltimore, 1992, Williams and Wilkins.
  12. CDC: Preventing transmission of infectious agents in healthcare settings, Centers for Disease Control and Prevention. Available at www.cdc.gov/. Accessed Sept. 24, 2010.
  13. Smith J, Dahm DL: Creatine use among select population of high school athletes. Mayo Clin Proc 75(12):1257–1263, 2000.
  14. Graham AS, Hatton RC: Creatine: a review of efficacy and safety. J Am Pharm Assoc 39(6):803–810, 1999.
  15. Metzl JD: Creatine use among young athletes. Pediatrics 108(2):421–425, 2001. Medline abstracts
  16. Inman RD: Arthritis and enteritis—an interface of protean manifestations. J Rheumatol 14:406–410, 1987. Medline abstracts
  17. Gran JT, Husby G: Joint manifestations in gastrointestinal diseases. Dig Dis 10:295–312, 1992. Medline abstracts
  18. Norman GF: Sacroiliac disease and its relationship to lower abdominal pain. Am J Surg 116:54–56, 1968. Medline abstracts
  19. Thjodleifsson B: A common genetic background for inflammatory bowel disease and ankylosing spondylitis. Arthritis Rheum 56:2633–2639, 2007. Medline abstracts
  20. Baeten D, et al: Influence of the gut and cytokine patterns in spondyloarthropathy. Clin Exp Rheumatol 20(6 Suppl 28):S38-S42, 2002.
  21. Sieper J, et al: Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays. Arthritis Rheum 46:319, 2002.
  22. Mustafa K, Khan MA: Recognizing and managing reactive arthritis. J Musculoskeletal Med 13(6):28–41, 1996.
  23. Burger EL: Lumbar disk replacement: restoring mobility. Orthopedics 27(4):386–388, 2004.
  24. Tay B, et al: Spinal infections. J Amer Acad Orthop Surg 10(3):188–197, 2002.
  25. Mallick IH: Iliopsoas abscesses. Postgrad Med J 80:459–462, 2004. Medline abstracts
  26. Goodman CC: The gastrointestinal system. In Goodman CC, Fuller KS, et al, editors: Pathology: implications for the physical therapist, ed 3, Philadelphia, 2009, WB Saunders.
  27. Sokolov KM, Kreye E, Miller LG, et al: Postpartum iliopsoas pyomyositis due to community-acquired methicillin-resistant Staphylococcus aureus. Obstet Gynecol 2007; 110:535–538.
  28. Shahabi S: Primary psoas abscess complicating a normal vaginal delivery. Obstet Gynecol 99:906–909, 2002. Medline abstracts
  29. Mandell GL: Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, ed 7, Philadelphia, 2009, Churchill Livingstone.
  30. Rayhorn N, Argel N, Demchak K: Understanding gastroesophageal reflux disease. Nursing2003 33(10):37–41, 2003.
  31. Sabesin SM, Fass R, Fisher R: Not all heartburn patients are equal: strategies for coping with gastroesophageal reflux disease (GERD), Medscape Continuing Medical Education.
  32. Aluka KJ: Guillain-Barré syndrome and postbariatric surgery polyneuropathies. JSLS 13(2):250–253, 2009. Medline abstracts
  33. Teitleman M: Polyneuropathy after gastric bypass surgery. Medscape General Medicine 7(2):2005, 2010. Available on-line at www.medscape.com/viewarticle/499484. Accessed on Sept. 21.
  34. Juhasz-Pocsine KN: Neurologic complications of gastric bypass surgery for morbid obesity. Neurology 68(21):1843–1850, 2007. Medline abstracts
  35. Asthma in older women. Harvard Women’s Health Watch 11(3):5, 2003.
  36. Margolis S: Getting the right cure for ulcers. Johns Hopkins Medical Letter 10(1):1–2, 1998.
  37. Miwa, H, Sakaki N, Sugano K, et al: Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients. Helicobacter 9(1):9–16, 2004. Medline abstracts
  38. Chan FKL, Graham DY: Prevention of non-steroidal anti-inflammatory drug gastrointestinal complications—review and recommendations based on risk assessment, Medscape Continuing Medical Education.
  39. Lanas A: Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice. Expert Opin Drug Safety July 20, 2010. Epub ahead of print.
  40. Wiegand T: Toxicity, Nonsteroidal anti-inflammatory agents, eMedicine Specialties: Emergency Medicine—Toxicity. Updated May 20, 2010. Available on-line at http://emedicine.medscape.com/article/816117-overview. Accessed January 31, 2011.
  41. McPhee S, Papadakis M, editors: Current medical diagnosis and treatment, ed 50, New York, 2011, Lange.
  42. Bronstein AC, Spyker DA, Cantilena LR Jr, et al: 2007 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 25th Annual Report. Clin Toxicol (Phila) 46(10):927–1057, 2008. Medline abstracts
  43. Chan FK: Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 347(26):2104–2110, 2002. Medline abstracts
  44. Sostres C: Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol 24(2):121–132, 2010. Medline abstracts
  45. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): H. pylori and peptic ulcers. Available on-line at http://digestive.niddk.nih.gov/ddiseases/pubs/hpylori/#2. Accessed January 31, 2011.
  46. Peloso PM: NSAIDs: a Faustian bargain. Am J Nurs 100(6):34–43, 2000. Medline abstracts
  47. Wolfe MM: Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 340(24):1888–1899, 1999. Medline abstracts
  48. Sturkenboom MC, Burke TA, Dieleman JP, et al: Underutilization of preventive strategies in patients receiving NSAIDs. Rheumatology (Oxford) 42(Suppl 3):iii23–31, 2003. Medline abstracts
  49. Goldstein JL: Challenges in managing NSAID-associated gastrointestinal tract injury. Digestion 69(Suppl 1):25–33, 2004. Medline abstracts
  50. Fries JF, et al: Nonsteroidal antiinflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med 91(3):213–222, 1991.
  51. Enns R: Acute lower gastrointestinal bleeding, Parts 1 and 2. Can J Gastroenterol 15:509–517, 2001. Medline abstracts
  52. Sadler TW: Langman’s medical embryology, ed 11, Philadelphia, 2009, Lippincott, Williams & Wilkins.
  53. Cheetham TC: Predicting the risk of gastrointestinal bleeding due to nonsteroidal antiinflammatory drugs: NSAID electronic assessment of risk. J Rheumatol 30(10):2241–2244, 2003. Medline abstracts
  54. National Institute of Diabetes and Digestive and Kidney Diseases: Diverticulosis and diverticulitis, NIH Publication 07–1163, October 2006. Available on-line at www.digestive.niddk.nih.gov. Accessed September 22, 2010.
  55. Rayhorn N: Inflammatory bowel disease (IBD). Nursing2003 33(11):54–55, 2003.
  56. Young-Fadok T: Clinical manifestations and diagnosis of colonic diverticular disease. Up-to-date November 19, 2008. Available (by subscription) on-line at www.uptodate.com. Accessed Sept. 24, 2010.
  57. Ma TY: Intestinal epithelial barrier dysfunction in Crohn’s disease. Proc Soc Exp Biol Med 214(4):318–327, 1997. Medline abstracts
  58. Wagner JM: Does this patient have appendicitis? JAMA 276(19):1589–1594, 1996. Medline abstracts
  59. Adams BD: Pinch-an-inch test for appendicitis. South Med J 98(12):1207–1209, 2005. Medline abstracts
  60. Adams BD: The Pinch-an-Inch test is more comfortable than rebound tenderness. Internet J Surg 12(2), 2007.
  61. Banks PA: Practice Parameters Committee of the American College of Gastroenterology. Practice Guidelines in acute pancreatitis. Am J Gastroenterol 101(10):2379–2400, 2006. Medline abstracts
  62. Ma TY, Iwamoto GK, Hoa NT, et al: TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 286(3):G367–G376, 2004. Medline abstracts
  63. Salim SY: Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis Aug 19, 2010. Epub ahead of print.
  64. Han X: Intestinal permeability as a clinical surrogate endpoint in the development of future Crohn’s disease therapies. Recent Pat Inflamm Allergy Drug Discov 4(2):159–176, 2010. Medline abstracts
  65. Shen L: Mechanisms and functional implications of intestinal barrier defects. Dig Dis 27(4):443–449, 2009. Medline abstracts
  66. Crowell MD, Dubin NH, Robinson JC, et al: Functional bowel disorders in women with dysmenorrhea. Am J Gastroenterol 89:1973, 1994.
  67. Heymen S: Central processing of noxious somatic stimuli in patients with irritable bowel syndrome compared with healthy controls. Clin J Pain 26(2):104–109, 2010. Medline abstracts
  68. Nokjov B: The impact of rotating shift work on the prevalence of irritable bowel syndrome in nurses. Am J Gastroenterol 105(4):842–847, 2010. Medline abstracts
  69. National Institutes of Health (NIH): Irritable bowel syndrome, NIH Publication No. 03–693, April, 2003.
  70. Jemal A: Cancer statistics 2010. CA Cancer J Clin 60(5):277–300, 2010. Medline abstracts
  71. Sargent C, Murphy D: What you need to know about colorectal cancer. Nursing2003 33(2):37–41, 2003.
  72. Smith R, et al: American Cancer Society guidelines for early detection of cancer. CA Cancer J Clin 52(1):8–22, 2002. Medline abstracts
  73. Lucak S: Diagnosing irritable bowel syndrome: what’s too much, what’s enough? Medscape Medical Continuing Education on line, posted 3/12/04 on www.medscape.com/viewarticle 465760.
  74. Schermer CR, et al: Ogilvie’s syndrome in the surgical patient: a new therapeutic modality. J. Gastroenterol Surg 3(2):173, 1999.
  75. el Maraghy A, et al: Ogilvie’s syndrome after lower extremity arthroplasty. Can J Surg 42(2):133, 1999.
  76. Richardson LC: Vital signs: colorectal cancer screening among adults ages 50–75 years in the United States. MMWR 59:1–5, 2010. Medline abstracts
  77. Sargent C, Murphy D: What you need to know about colorectal cancer. Nursing2003 33(2):37–41, 2003.
  78. Smith R, et al: American Cancer Society guidelines for early detection of cancer. CA Cancer J Clin 52(1):8–22, 2002. Medline abstracts
  79. Soetikno RM: Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 299(9):1027–1035, 2008. Medline abstracts
  80. CR Schermer, et al: Ogilvie’s syndrome in the surgical patient, a new therapeutic modality. J Gastroenterol Surg 3(2):173, 1999.
  81. Oberpenning F, Roth S, Leusmann DB, et al: The Alcock syndrome: temporary penile insensitivity due to compression of the pudendal nerve within the Alcock canal. J Urol 151(2):423–425, 1994. Medline abstracts
  82. Weiss BD: Clinical syndromes associated with bicycle seats. Clin Sports Med 13(1):175–186, 1994. Medline abstracts